Stage I-IIA lung cancer
Conditions
Interventions
Proto beam therapy: 4 times 15 Gy(BED)
Sponsors
Harada Hideyuki
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Inoperable stage I-IIA lung cancer according to the Lung Cancer without hilar lymph node metastasis 2) 18 years of age or older 3) Sufficient pulmonary function 4) written consent to the study 5) Expected to survive for more than 6 months or more 6) It has been determined by the radiation therapist that treatment can be performed according to the protocol.
Exclusion criteria
Exclusion criteria: 1) Previous Radiotherapy to ipsilateral lung 2) Active double cancer 3) Interstitial pneumonia or pulmonary fibrosis on chest CT 4) Implantable medical devices such as pacemakers, defibrillators, ventricular assist devices, cerebrospinal cord stimulators cochlear implants, etc. 5) Women who are pregnant or with possible pregnancy, breastfeeding or who are not willing to use contraception 6) Inappropriate for participating in this study judged by the attending physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feasibility | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse events Progression-free survival Overall survival Site of recurrence Treatment time required for each irradiation Local progression-free survival Local control period | — |
Contacts
Public ContactHideyuki Harada
Shizuoka Cancer Center
Outcome results
None listed